South Florida Medical Research   Report issue

For profit Phase 3
Founded: Aventura FL United States (1992)

Organization Overview

First Clinical Trial
2009
NCT01038843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

fedovapagon (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperplasia (Phase 3)

Nocturia (Phase 3)

Prostatic Hyperplasia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1